Evidence-Based Medicine Guidelines
PCSK9 inhibitors for prevention of cardiovascular disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"PCSK9 Inhibitors for Prevention of Cardiovascular Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305377/all/PCSK9_inhibitors_for_prevention_of_cardiovascular_disease.
PCSK9 inhibitors for prevention of cardiovascular disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305377/all/PCSK9_inhibitors_for_prevention_of_cardiovascular_disease. Accessed October 4, 2024.
PCSK9 inhibitors for prevention of cardiovascular disease. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305377/all/PCSK9_inhibitors_for_prevention_of_cardiovascular_disease
PCSK9 Inhibitors for Prevention of Cardiovascular Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305377/all/PCSK9_inhibitors_for_prevention_of_cardiovascular_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - PCSK9 inhibitors for prevention of cardiovascular disease
ID - 1305377
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305377/all/PCSK9_inhibitors_for_prevention_of_cardiovascular_disease
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
